Earnings Preview For Harvard Bioscience
Portfolio Pulse from Benzinga Insights
Harvard Bioscience (NASDAQ:HBIO) is set to release its latest quarterly earnings report on Tuesday, 2023-11-07. Analysts estimate an earnings per share (EPS) of $0.04. The company's past performance shows a mixed trend with the last quarter missing EPS by $0.01, resulting in a 1.81% drop in the share price. However, the stock has seen a 75.21% increase over the last 52-week period.
November 06, 2023 | 7:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Harvard Bioscience is expected to report an EPS of $0.04 in its upcoming earnings. The company's stock price may be affected by the earnings report and any guidance provided.
The company's stock price has shown to be sensitive to its earnings reports in the past. Last quarter, the company missed its EPS estimate by $0.01, which resulted in a 1.81% drop in the share price. However, the stock has been performing well over the past year, with a 75.21% increase. The upcoming earnings report and any guidance provided by the company could have a significant impact on the stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100